News

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...
COMMENT: As a Black woman in a white-dominated sport, Williams experienced unique pressures. Yet to see someone of her ...